Ask AI
H.R. 2999

Patients' Access to Treatments Act of 2017

Patients' Access to Treatments Act of 2017

This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.

Referred to the Subcommittee on Health.

Rep. McKinley, David B. [R-WV-1](R-WV)Sponsor
35 cosponsors27 D8 R
35cosponsors1committees4actions3subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Patients' Access to Treatments Act of 2017 — Informed